1. Home
  2. IQV vs GRMN Comparison

IQV vs GRMN Comparison

Compare IQV & GRMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • GRMN
  • Stock Information
  • Founded
  • IQV 1982
  • GRMN 1990
  • Country
  • IQV United States
  • GRMN Switzerland
  • Employees
  • IQV N/A
  • GRMN N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • GRMN Industrial Machinery/Components
  • Sector
  • IQV Health Care
  • GRMN Industrials
  • Exchange
  • IQV Nasdaq
  • GRMN Nasdaq
  • Market Cap
  • IQV 35.7B
  • GRMN 41.4B
  • IPO Year
  • IQV 2013
  • GRMN 2000
  • Fundamental
  • Price
  • IQV $190.98
  • GRMN $224.57
  • Analyst Decision
  • IQV Strong Buy
  • GRMN Hold
  • Analyst Count
  • IQV 17
  • GRMN 5
  • Target Price
  • IQV $251.00
  • GRMN $200.60
  • AVG Volume (30 Days)
  • IQV 1.4M
  • GRMN 922.6K
  • Earning Date
  • IQV 02-06-2025
  • GRMN 02-19-2025
  • Dividend Yield
  • IQV N/A
  • GRMN 1.33%
  • EPS Growth
  • IQV 2.74
  • GRMN 8.79
  • EPS
  • IQV 7.49
  • GRMN 7.30
  • Revenue
  • IQV $15,405,000,000.00
  • GRMN $6,296,903,000.00
  • Revenue This Year
  • IQV $5.17
  • GRMN $20.17
  • Revenue Next Year
  • IQV $6.04
  • GRMN $8.91
  • P/E Ratio
  • IQV $25.51
  • GRMN $30.78
  • Revenue Growth
  • IQV 2.81
  • GRMN 20.44
  • 52 Week Low
  • IQV $187.62
  • GRMN $133.16
  • 52 Week High
  • IQV $261.73
  • GRMN $246.50
  • Technical
  • Relative Strength Index (RSI)
  • IQV 37.76
  • GRMN 56.44
  • Support Level
  • IQV $192.10
  • GRMN $201.63
  • Resistance Level
  • IQV $198.90
  • GRMN $246.50
  • Average True Range (ATR)
  • IQV 5.43
  • GRMN 7.04
  • MACD
  • IQV -1.28
  • GRMN 1.32
  • Stochastic Oscillator
  • IQV 0.75
  • GRMN 51.13

About IQV IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About GRMN Garmin Ltd. (Switzerland)

Garmin produces GPS-enabled hardware and software for five verticals: fitness, outdoors, auto, aviation, and marine. The company relies on licensing mapping data to enable its hardware specialized for often niche activities like scuba diving or sailing, among many others. Garmin operates in 100 countries and sells its products via distributors as well as relationships with original equipment manufacturers.

Share on Social Networks: